Snapshots

Search

Search managers or tickers

RXRX Recursion Pharmaceuticals In

held 2.5 yr · 10 quarters on record · no longer held RXRX across all managers
Position over time
PeriodShares% of portfolioActivityValue
Q4 2023 906,767 0.29% $9M
Q3 2023 906,767 0.25% Reduce 34.6% $7M
Q2 2023 1,385,950 0.36% $10M
Q1 2023 1,385,950 0.40% $9M
Q4 2022 1,385,950 0.53% $11M
Q3 2022 1,385,950 0.85% Add ×5.1 $15M
Q2 2022 273,650 0.16% $2M
Q1 2022 273,650 0.09% Add 5.3% $2M
Q4 2021 259,941 0.16% $4M
Q3 2021 259,941 0.19% NEW $6M